Patrick Parkin Partner

Patrick is a partner specialising in contract, procurement and regulatory matters in Healthcare and Tech. He is recognised as a leader in his field by Legal 500 (where he is ranked as a “Next Generation Partner”) and Chambers Legal.

He advises clients across the healthcare, tech and life sciences sectors, in the UK and internationally, from start-ups to some of the highest profile tech disruptors in the market. He also works with central government and NHS bodies procuring their healthcare and tech arrangements.

• Advising a global provider of cloud services on its cloud services arrangements with government customers across EMEA.
• Advising an NHS Foundation Trust relation to its competitive procurement for community pharmacy services, with a contract value in excess of £1bn and in relation to its arrangements with independent providers to provide additional theatre capacity for cancer patients.
• Leading the Burges Salmon team advising the government’s Vaccine Taskforce throughout the Covid-19 pandemic, in relation to vaccine manufacturing arrangements.
• Advising GAVI, the Vaccine Alliance, in relation to the funding of vaccine programmes to reach “zero dose children” in Africa.
• Advising an international telemedicine provider in relation to its regulatory obligations on entry to the UK market.
• Advising the Department of Health and Social Care in relation to the establishment of the “Dedicated Health Channel” – part of HMG’s Brexit preparations to ensure the supply of medicines and medical devices post-Brexit.
• Advising a US-owned provider of medical devices on its supply arrangements with the NHS, comprising both commercial contract and procurement law advice.
• Advising a private hospital group on the scope of its regulatory obligations and practical advice to comply with its CQC obligations and best practice guidance.
• Advising a private provider of community healthcare services to the NHS in relation to a range of contractual partnership arrangements with NHS bodies.
• Advising a not-for-profit provider of PET-CT diagnostic imaging services on its contractual arrangements with NHS England and private sector sub-contractors.